Wall Street is asking how weight loss drugs will affect consumer giants — but it may be too early to tell
Publishing timestamp: 2023-11-07 08:05:16
Summary
The article discusses how GLP-1 drugs, used for diabetes and obesity, are potentially affecting the bottom lines of various companies. While some analysts believe that these drugs will reshape industries, it is still unclear how many people will actually take them and for how long. The article highlights the potential market size of $100 billion by the end of the decade, but also mentions the limitations and side effects of these drugs. The article concludes by stating that this theme of weight loss drugs will continue to be relevant in the future as more drugs are developed and payers make decisions.
Sentiment: NEUTRAL
Tickers: DAL, DRI, NSRGF, PEP, CAG, HSY, PM, NES.N-CH,
Keywords: food and drink, darden restaurants inc, hershey co, conagra brands inc, health care industry, business news, pepsico inc., nestle sa, delta air lines inc, philip morris international inc,
Source: https://www.cnbc.com/2023/11/06/weight-loss-drug-frenzy-hits-consumer-giants-in-earnings-season.html